Preliminary experiments show conolidine may possibly inhibit certain ion channels, lessening neuronal excitability and limiting suffering indicators. This system is particularly applicable in neuropathic agony, in which irregular signaling causes persistent pain. Also, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to suffering perception. Computational... https://carlosv737sxz5.targetblogs.com/profile